New deal for EQiTX offshoot

BIOTECHNOLOGY company ZingoTX Pty Ltd, a subsidiary of Perth-based biotech EQiTX, has signed licence and ancillary agreements with the University of Sydney to develop pain and anti-inflammation drugs.